AstraZeneca sells US, Canada rights of Seroquel drugs to Cheplapharm

This article was originally published here

The transaction has been taken up by AstraZeneca as the compound patent protection of the two drugs is no longer valid in the two countries. It would also

The post AstraZeneca sells US, Canada rights of Seroquel drugs to Cheplapharm appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply